Marinus Pharma Cash Flow - Annual (NASDAQ:MRNS)

Add to My Stocks
$7.56 $0.56 (8%) MRNS stock closing price Sep 18, 2018 (Closing)

The Marinus Pharma cash flow statement helps investors understand how well the company is managing its cash flows. Financials statements like the Marinus Pharma income statement and Marinus Pharma balance sheet show that the company has profits and debt, while the cash flow statement provides details of cash flow movments. Marinus Pharma cash flow analysis is possible because this statement breaks down how balance sheet accounts and income statement items affect cash and cash equivalents. Marinus Pharma had cash and cash equivalents of $26.17M at the beginning of the year and $33.53M at year end for 2017. MRNS decrease in investments stood at a value of $-21.42M for the latest year 2017.

View details of Marinus Pharma cash flows for latest & last 10 financial years
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Jan - Dec201720162015201420132012
Net Income Cash Flow
-18.89M-28.64M-24.85M-10.83M-5.26M-1.4M
Depreciation Depletion Amortization Cash-Flow------
Net Increase (Decrease) in Assets Liabilities-2.9M-2.59M2.72M-1.54M-
Cash From (used in) Discontinued Operations------
Other Adjustments Net2.88M3.07M2.11M-0.49M--
Net Cash from (used by) Operating Activities
-18.81M-24.76M-20.12M-8.58M-6.62M-1.22M
Increase (Decrease) in Prop Plant And Equipment-0.45M-0.64M--0.03M-0.01M-0.01M
Acquisition Disposition of Subsidiaires------
Increase (Decrease) in Investments-20.97M2.04M-5.96M---
Other Cash Inflow (Outflow) from Investment Activities---0.35M---
Net Cash from (used by) Investment Activities
-21.42M1.39M-6.31M-0.03M-0.01M-0.01M
Issuance (Purchase) of Equity Shares52.64M-0.04M28.65M41.33M7.54M8.58M
Issuance (Repayment) of Debt Securities------
Increase (Decrease) in Bank & Other Borrowings-5.05M-2.12M-0.2M6.97M--
Payment of Dividends & Other Cash Distributions------
Other Cash from (used by) Financing Activities------
Net Cash from (used by) Financing Activities
47.58M-2.17M28.44M48.3M8.04M8.88M
Effect of Exchange Rate Changes on Cash------
Net Change in Cash & Cash Equivalents
7.35M-25.54M2M39.68M1.4M7.64M
Cash & Equivalents at Beginning of Year26.17M51.72M49.72M10.03M8.63M-
Cash & Equivalents at Year End33.53M26.17M51.72M49.72M10.03M8.63M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

The statement of cash flows comprises of cash flow from financing, cash flow from operations and cash flow from investing activities. All the three can have an impact on the stock price. The Marinus Pharma stock price history and Marinus Pharma stock comparison chart inevitably reflect its cash flow situation.

  • Net Change in Cash and Cash Equivalents: A positive net change in cash and cash equivalents shows that Marinus Pharma is able to meet its expenditure and grow cash at hand which demonstrates the financial strength of the company's balance sheet. Also see - Marinus Pharma stock price movement.
  • Cash Flow from operating activities: This is the cash that the company receives from ongoing operations. Marinus Pharma lost $-18.81M cash from operations. It is important to check this to see where the company is getting its money from.
  • Cash Flow from investment activities: This includes buying/selling of land and equipment, acquisitions and mergers, sell-off, investment in other companies like buying bonds, stocks etc., and was $-21.42M for MRNS in last 2017 report.
  • Cash flow from financing activities shows the flow of cash between Marinus Pharma and its owners and creditors and was $47.58M for 2017. Financing activities allow a company to raise capital, and repay bondholders.

Key Financial Ratios For Marinus Pharma Cash Flow

Annual Cash Flow Statements For Marinus Pharmaceuticals Inc Peers

Affirmed cash flow, Corbus Pharmaceuticals cash flow, Eisai cash flow, GlaxoSmithKline cash flow